Cargando…
Novel scaffolds for inhibition of Cruzipain identified from high-throughput screening of anti-kinetoplastid chemical boxes
American Trypanosomiasis or Chagas disease is a prevalent, neglected and serious debilitating illness caused by the kinetoplastid protozoan parasite Trypanosoma cruzi. The current chemotherapy is limited only to nifurtimox and benznidazole, two drugs that have poor efficacy in the chronic phase and...
Autores principales: | Salas-Sarduy, Emir, Landaburu, Lionel Urán, Karpiak, Joel, Madauss, Kevin P., Cazzulo, Juan José, Agüero, Fernán, Alvarez, Vanina Eder |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608908/ https://www.ncbi.nlm.nih.gov/pubmed/28935948 http://dx.doi.org/10.1038/s41598-017-12170-4 |
Ejemplares similares
-
Author Correction: Novel scaffolds for inhibition of Cruzipain identified from high-throughput screening of anti-kinetoplastid chemical boxes
por: Salas-Sarduy, Emir, et al.
Publicado: (2018) -
Potent and selective inhibitors for M32 metallocarboxypeptidases identified from high-throughput screening of anti-kinetoplastid chemical boxes
por: Salas-Sarduy, Emir, et al.
Publicado: (2019) -
TDR Targets 6: driving drug discovery for human pathogens through intensive chemogenomic data integration
por: Urán Landaburu, Lionel, et al.
Publicado: (2020) -
Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against Trypanosoma cruzi
por: Cerny, Natacha, et al.
Publicado: (2020) -
Divergent polo box domains underpin the unique kinetoplastid kinetochore
por: Nerusheva, Olga O., et al.
Publicado: (2016)